  0 Table of Contents |
  1 Home |
  2 Profiles |
  3 Extensions |
  4 Terminology |
  5 Examples |
  6 Downloads |
  7 Version History |
   8 Artifacts Summary |
   8.1 FI Base Appointment |
   8.2 FI Base Condition |
   8.3 FI Base Encounter |
   8.4 FI Base EpisodeOfCare |
   8.5 FI Base HealthcareService |
   8.6 Fi Base Immunization |
   8.7 FI Base Location |
   8.8 FI Base Medication |
   8.9 FI Base MedicationAdministration |
   8.10 FI Base MedicationRequest |
   8.11 FI Base MedicationStatement |
   8.12 FI Base Observation |
   8.13 FI Base Organization |
   8.14 FI Base Patient |
   8.15 FI Base Practitioner |
   8.16 FI Base PractitionerRole |
   8.17 Fi Base Procedure |
   8.18 FI Base Provenance |
   8.19 FI Base Reason for Care (encounter-diagnosis and reason for visit) |
   8.20 FI Base Schedule |
   8.21 FI Base Slot |
   8.22 Categorization of the type of accident |
   8.23 Cause of an adverse effect |
   8.24 Endocrinological disorder |
   8.25 External cause for diagnosis |
   8.26 Medication that caused this condition |
   8.27 Municipality Code |
   8.28 Patient Profession Extension |
   8.29 Permanence of condition |
   8.30 Primary condition for encounter |
   8.31 RegisterSpecifier |
   8.32 RegisterTypeCode |
   8.33 Type of physical exercise during which injury occurred. |
   8.34 Vaccination Recorder |
   8.35 Finnish ValueSet for security labels in accordance with finnish authorities |
   8.36 Finnish CodeSystem for security labels |
   8.37 1 tabletti 2 kertaa päivässä |
   8.38 1 tabletti 2 kertaa päivässä 5 päivän ajan 15.1.2021 alkaen |
   8.39 1 tabletti 2 kertaa päivässä 5-7 päivän ajan 15.1.2021 alkaen |
   8.40 1-2 tablettia 1-3 kertaa päivässä |
   8.41 1-2 tablettia kerran päivässä |
   8.42 2 tablettia aamulla ja 1 tabletti illalla 6 päivän ajan |
   8.43 A high level organization |
   8.44 A named bed |
   8.45 A simple practitioner role |
   8.46 Another Encounter that is part of palvelutapahtuma |
   8.47 b88191e3-ea47-4feb-9da9-e3b359fa8fca |
   8.48 Biopsy of Colon procedure example |
   8.49 care-plan-optional |
   8.50 Codified healthcare service |
   8.51 Condition - an example diagnosis |
   8.52 Condition - an example diagnosis with an adverse effect. |
   8.53 Condition - an example diagnosis with external cause, accident and medication information. |
   8.54 Custodian of information (rekisterinpitäjä) |
   8.55 Encounter - example primary care organization |
   8.56 Encounter - patient is currently receiving care at a ward treating surgical patients |
   8.57 Encounter - patient primary care visit |
   8.58 Encounter that is a palvelutapahtuma in Kanta registry |
   8.59 Encounter that is part of palvelutapahtuma |
   8.60 Episode of care - with provenance |
   8.61 Free slot (kertakäynti yleislääkärillä) |
   8.62 GP appointment |
   8.63 Kanta PHR - blood glucose mandatory |
   8.64 Kanta PHR - blood glucose optional |
   8.65 Kanta PHR - blood glucose result as text |
   8.66 Kanta PHR - blood glucose with data absent |
   8.67 Kanta PHR - blood pressure mandatory |
   8.68 Kanta PHR - blood pressure optional |
   8.69 Kanta PHR - body height optional |
   8.70 Kanta PHR - body weight mandatory |
   8.71 Kanta PHR - body weight optional |
   8.72 Kanta PHR - calorie intake mandatory |
   8.73 Kanta PHR - calorie intake optional |
   8.74 Kanta PHR - carbohydrate intake mandatory |
   8.75 Kanta PHR - carbohydrate intake optional |
   8.76 Kanta PHR - exercise tracking mandatory |
   8.77 Kanta PHR - exercise tracking optional |
   8.78 Kanta PHR - Insulin dosage mandatory |
   8.79 Kanta PHR - Insulin dosage optional |
   8.80 Kanta PHR - MET measurement mandatory |
   8.81 Kanta PHR - MET measurement optional |
   8.82 Kanta PHR - patient 3 |
   8.83 Kanta PHR - physical activity mandatory |
   8.84 Kanta PHR - physical activity optional |
   8.85 Kanta PHR - step count mandatory |
   8.86 Kanta PHR - step count optional |
   8.87 Karen van der Hentenryck |
   8.88 Lars van der Knaapi |
   8.89 Licenced physician |
   8.90 Licenced physician in primary care |
   8.91 Lääke tauolla 1.3.2020 - 30.6.2020. Taukoa edeltävä annostus: 25 mg klo 08:00 10 päivän ajan ihon alle |
   8.92 Maanantaisin 1 tabletti ja tarvittaessa keskiviikkoisin 0,5 tablettia 01.06.2020 - 31.12.2020 |
   8.93 MedicationAdministration example of insulin basal dose |
   8.94 MedicationAdministration example of insulin dose |
   8.95 MedicationAdministration example of temporary basal rate |
   8.96 Myyntiluvallinen lääkevalmiste |
   8.97 Myyntiluvallinen lääkevalmiste, joka on PKV-lääke |
   8.98 Organization - example of a parent organization |
   8.99 Organization - example primary care organization |
   8.100 Outpatient clinic |
   8.101 Patient - has TURVAKIELTO security label. |
   8.102 Patient - with the MunicipalityCode extension. |
   8.103 Patient generated glucose observations and insulin administrations as a bundle, in English |
   8.104 Patient generated glucose observations and insulin administrations as a bundle, in Finnish |
   8.105 Patient generated glucose observations and insulin administrations as a bundle, in Swedish |
   8.106 Procedure Colotomy example |
   8.107 Simple Organization example |
   8.108 SNOMED CT coded Schedule |
   8.109 Tarvittaessa 1-2 tippaa 3-4 tunnin välein |
   8.110 Tarvittaessa 2 tablettia 3 kertaa viikossa 16.2.2021 alkaen |
   8.111 Testi terveysasema |
   8.112 Vaccination for TBE |
   8.113 |
   8.114 |
   8.115 |
   8.116 |
   8.117 |
   8.118 |
   8.119 |
   8.120 |